Source:http://linkedlifedata.com/resource/pubmed/id/10401374
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1999-12-17
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
N
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0174-108X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32-4
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:10401374-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10401374-Europe,
pubmed-meshheading:10401374-Female,
pubmed-meshheading:10401374-Germany,
pubmed-meshheading:10401374-Humans,
pubmed-meshheading:10401374-Infusions, Intravenous,
pubmed-meshheading:10401374-Neoplasm Staging,
pubmed-meshheading:10401374-Ovarian Neoplasms
|
pubmed:articleTitle |
[What is current status? Current status in the primary therapy of advanced ovarian cancer].
|
pubmed:publicationType |
Journal Article
|